Silver Diamine Fluoride: Caries Arrest and Clinical Applications

Introduction

Dental caries remains one of the most prevalent chronic diseases worldwide, disproportionately affecting children, elderly populations, and communities with limited access to conventional restorative care. The traditional restorative approach requires expensive equipment, cooperative patients, and multiple clinical visits—barriers that have driven the search for minimally invasive, cost-effective alternatives. Silver diamine fluoride (SDF) has emerged as one of the most significant innovations in non-restorative caries management over the past decade, offering a simple topical application that arrests carious lesions without the need for local anesthesia or rotary instrumentation.

SDF is a colorless alkaline solution containing approximately 24.4% to 28.8% (w/v) silver and 5.0% to 5.9% (w/v) fluoride. Its dual mechanism of action—combining the antimicrobial properties of silver ions with the remineralization potential of fluoride—makes it uniquely effective at halting caries progression. First approved by the U.S. Food and Drug Administration (FDA) in 2014 for dentinal hypersensitivity and later cleared for caries arrest, SDF has been adopted into clinical practice guidelines by the American Academy of Pediatric Dentistry (AAPD), the American Dental Association (ADA), and numerous international dental organizations.

This article provides a comprehensive review of SDF, tracing its historical development, examining the biochemical mechanisms underlying its efficacy, detailing evidence-based clinical protocols, discussing aesthetic considerations and management of the characteristic black staining, and exploring its expanding role in contemporary minimally invasive dentistry across diverse patient populations.

Historical Background and Regulatory Development

The use of silver compounds in dentistry dates back over a century. Silver nitrate was employed for caries arrest as early as the 1840s, with Dr. J. Howe advocating its application in primary teeth. The combination of silver nitrate with fluoride was pioneered in Japan during the 1960s, where Dr. Nishino and colleagues at Osaka University developed what became known as "Saforide"—the precursor to modern SDF formulations. Japanese regulatory authorities approved SDF for caries treatment in 1970, and it has been used extensively in that country's school-based dental programs for over five decades.

In the United States, the regulatory pathway was more protracted. The FDA cleared SDF (Advantage Arrest, Elevate Oral Care) for treating dentinal hypersensitivity in 2014. In 2016, the FDA granted breakthrough therapy designation and subsequently cleared SDF for caries arrest, recognizing it as a significant advance over existing treatments. The AAPD adopted SDF into its clinical practice guidelines in 2017, recommending its use for caries arrest in primary and permanent teeth. China, Australia, Brazil, and numerous other nations have since incorporated SDF into their public health arsenals, with the World Health Organization including SDF in its Model List of Essential Medicines for both adults and children in 2021.

Mechanism of Action

The caries-arresting efficacy of SDF derives from a synergistic interplay between its silver and fluoride components, each targeting different aspects of the caries process.

Silver ions (Ag+) exert potent antimicrobial effects through multiple pathways. They bind to bacterial cell wall proteins and enzymes containing thiol (-SH) groups, disrupting membrane integrity and inhibiting essential metabolic functions. Silver ions also interact with bacterial DNA, preventing replication, and generate reactive oxygen species that induce oxidative stress within the biofilm. The broad-spectrum activity of silver targets both gram-positive and gram-negative organisms, including Streptococcus mutans, Lactobacillus species, and Actinomyces—the primary cariogenic pathogens. Furthermore, silver inhibits the activity of matrix metalloproteinases (MMPs) and cathepsins within dentin, thereby reducing collagen degradation and preserving the dentin matrix scaffold.

Fluoride ions facilitate remineralization by promoting the formation of fluorapatite (Ca5(PO4)3F), which is more resistant to acid dissolution than hydroxyapatite. Fluoride also inhibits enolase, a key enzyme in the glycolytic pathway of cariogenic bacteria, reducing acid production within the biofilm. Additionally, fluoride enhances the precipitation of calcium phosphate onto demineralized tooth surfaces, shifting the equilibrium toward mineral gain.

A defining feature of SDF-treated lesions is the formation of a dense, mineralized surface layer that acts as a physicochemical barrier. Scanning electron microscopy (SEM) and energy-dispersive X-ray spectroscopy (EDS) reveal that this layer contains elevated concentrations of silver, calcium, and phosphorus, suggesting the precipitation of silver phosphate and calcium fluoride compounds. Transmission electron microscopy (TEM) studies demonstrate silver nanoparticle penetration into dentinal tubules, where they occlude the tubules and provide sustained antimicrobial activity. The depth of silver penetration can reach 50 to 200 micrometers into demineralized dentin, effectively "fossilizing" the lesion and preventing further bacterial invasion and acid dissolution.

Recent research has also elucidated SDF's effect on the dentin organic matrix. The inhibition of collagenolytic enzymes by silver ions preserves the type I collagen scaffold, which is critical for maintaining dentin structural integrity and providing a template for potential remineralization. This dual mechanism targeting both the mineral and organic phases of dentin distinguishes SDF from conventional fluoride therapies, which primarily affect the mineral phase.

Clinical Protocol and Application Technique

The clinical application of SDF is straightforward and requires minimal armamentarium, making it suitable for use in traditional operatory settings, community outreach programs, and even non-dental healthcare environments. The standard protocol, as endorsed by the AAPD and ADA, involves the following steps.

First, perform a thorough clinical and radiographic examination to diagnose carious lesions and assess pulp health. SDF is contraindicated for lesions with clinical or radiographic signs of irreversible pulpitis, pulpal necrosis, or periapical pathology. Lesions should be accessible for direct visualization and application.

Second, isolate the tooth to be treated using cotton rolls, gauze, or a rubber dam. Relative isolation with cotton rolls is typically sufficient, though care must be taken to protect the gingiva and oral mucosa from unintentional SDF contact, as it can cause temporary staining and mild chemical burns. The application of petroleum jelly or a similar protective barrier to the lips and perioral skin can prevent accidental staining.

Third, remove gross debris and superficial plaque from the cavitated lesion using a microbrush, cotton pellet, or excavator. Extensive cavity preparation is not necessary, as SDF is intended for non-restorative caries arrest. The goal is to expose the carious dentin surface to maximize SDF contact.

Fourth, dry the lesion with compressed air or cotton pellets. Excess moisture can dilute SDF and reduce its efficacy, though complete desiccation is not required.

Fifth, apply one to two drops of SDF directly to the lesion using a microbrush. The volume used is minimal—typically 1 drop (approximately 0.025 mL) per lesion, with a recommended maximum of 1 drop per 10 kilograms of body weight per treatment visit to stay well below toxic thresholds. The SDF should be applied only to the affected tooth surface, avoiding contact with the gingiva and surrounding mucosa.

Sixth, allow the SDF to remain on the lesion for a minimum of one minute and ideally up to three minutes for maximum penetration. During this time, the lesion will typically turn black as silver compounds precipitate—this color change is a normal and expected outcome that indicates successful chemical reaction.

Seventh, remove excess SDF with a cotton pellet or gauze, and rinse the area thoroughly with water. The patient should be instructed not to eat or drink for at least 30 minutes following application to maximize fluoride uptake.

The standard recall interval for SDF reapplication is 6 to 12 months. Lesions that do not show arrest (hard, dark, and shiny surface upon probing) at recall should be re-treated. The AAPD recommends biannual application for optimal caries arrest rates, though annual application may be sufficient in lower-risk populations. SDF treatment can be combined with glass ionomer cement (GIC) restorations or stainless steel crowns in a technique known as silver-modified atraumatic restorative treatment (SMART), where SDF is applied to the cavity floor prior to restoration placement to provide additional antimicrobial protection against residual caries.

Evidence of Efficacy

The clinical efficacy of SDF for caries arrest has been established through a robust body of evidence including randomized controlled trials, systematic reviews, and meta-analyses spanning diverse populations and settings.

A landmark systematic review by Gao et al. (2016), published in the Journal of Dental Research, analyzed 19 clinical trials and reported an overall caries arrest rate of 81% for SDF-treated lesions. The meta-analysis demonstrated that 38% SDF (the most commonly studied concentration) was significantly more effective than fluoride varnish, with an odds ratio of 2.42 for caries arrest in primary teeth. Annual reapplication further improved outcomes, with arrest rates exceeding 90% in several studies.

Chibinski et al. (2017) conducted a meta-analysis of 12 randomized controlled trials comparing SDF with other caries-arresting agents. SDF 38% achieved a mean caries arrest rate of 65.9% (range 44.7%-89.3%), which was significantly superior to both placebo (24.8%) and fluoride varnish (43.8%). The number needed to treat (NNT) was approximately 2, indicating that for every two lesions treated with SDF, one additional lesion would be arrested compared to placebo.

Fung et al. (2018) evaluated SDF in a school-based caries prevention program in Hong Kong involving over 600 preschool children. The biannual application of 38% SDF arrested 79% of active carious lesions after 30 months, compared to 61% for 12% SDF and 56% for placebo. A parallel study by Duangthip et al. (2018) in a community setting in Hong Kong reported 85% arrest rates for SDF 38% applied annually over 36 months in primary anterior teeth.

In permanent teeth, the evidence base is growing. A randomized clinical trial by Zhi et al. (2012) demonstrated that 38% SDF arrested 66.7% of root caries lesions in community-dwelling elderly adults after 24 months, compared to 34.5% for oral health education alone. Li et al. (2019) reported similar findings, with SDF achieving 71% arrest of root caries in institutionalized elderly patients over 30 months. These results have significant implications for geriatric dental care, where conventional restorative treatment may be complicated by medical comorbidities, limited access, and financial constraints.

A 2023 network meta-analysis by Urquhart et al. synthesized evidence from 47 randomized trials and confirmed SDF as the most effective non-restorative caries treatment, ranking above fluoride varnish, chlorhexidine, casein phosphopeptide-amorphous calcium phosphate (CPP-ACP), and sealants for caries arrest in both primary and permanent teeth. The analysis estimated that SDF 38% applied biannually would arrest approximately 80% of treated lesions over 24 months.

Aesthetic Considerations and Staining Management

The primary and most frequently cited drawback of SDF treatment is the permanent black staining of arrested carious lesions. This discoloration results from the precipitation of silver phosphate and silver oxide compounds within the demineralized dentin. While the staining confirms treatment efficacy and provides a visual indicator of successful arrest, it can be aesthetically unacceptable, particularly in the anterior region and in smile-displaying posterior teeth.

Parental and patient acceptance of SDF staining varies by tooth location and cultural context. Studies consistently report high acceptance rates (80-95%) for posterior teeth, while acceptance for anterior teeth is lower (50-70%). Crystal et al. (2017) surveyed 1,200 parents and found that 67% would accept SDF treatment for their child's anterior teeth if it meant avoiding sedation or general anesthesia. In many Asian countries where SDF has been used for decades, the staining is broadly accepted as a trade-off for caries arrest.

Several strategies have been developed to mitigate or mask SDF staining. The application of potassium iodide (KI) immediately after SDF has been proposed as a method to reduce discoloration. The reaction between silver ions and iodide forms a yellowish silver iodide precipitate (AgI) instead of the black silver phosphate. However, clinical studies have shown mixed results, with some reporting reduced staining and others finding no significant difference compared to SDF alone. Furthermore, the addition of KI may decrease the antimicrobial efficacy of SDF by consuming free silver ions, though the clinical significance of this interaction remains debated.

Post-treatment restoration with glass ionomer cement or composite resin over the arrested lesion, as performed in the SMART technique, effectively masks the discoloration. For anterior teeth, this approach allows the caries-arresting benefits of SDF to be realized while maintaining acceptable aesthetics. Timing of restoration placement varies: some clinicians prefer immediate restoration, while others advocate waiting 2-4 weeks to confirm lesion arrest before restoring.

Recent innovations in SDF formulation aim to address the staining issue. Nano-silver fluoride (NSF) preparations and SDF formulations incorporating reducing agents to control silver particle size and oxidation state are under investigation. Additionally, ammonium hexafluorosilicate (AHF) and silver nanoparticles combined with chitosan have shown promise as alternative approaches that maintain antimicrobial activity with reduced or eliminated staining. Several of these experimental formulations are in early clinical trials, and the coming years are likely to bring commercially available staining-reduced SDF products.

Safety and Adverse Effects

SDF has an excellent safety profile when used according to established clinical guidelines. The primary safety concerns relate to acute toxicity from ingestion, chronic systemic effects from silver accumulation, and local tissue reactions.

Acute fluoride toxicity from SDF is extremely unlikely given the small volumes used clinically. The typical application of 0.025 mL of 38% SDF contains approximately 1.4 mg of fluoride—well below the probably toxic dose (PTD) of 5 mg/kg body weight. For a 10 kg child, the PTD would be 50 mg, equivalent to approximately 1.25 mL of SDF or 50 drops—a volume far exceeding any clinical application. Nevertheless, clinicians should adhere to the recommended maximum dose of 1 drop per 10 kg per visit and store SDF in child-resistant containers.

Systemic silver absorption has been studied through blood and urine monitoring following SDF application. Vasquez et al. (2012) measured serum silver levels in children before and after SDF treatment and found no detectable increase, indicating negligible systemic absorption from a single application. Long-term accumulation concerns are also minimal, as the total silver dose from biannual SDF applications over a childhood caries treatment course is orders of magnitude below levels associated with argyria (3-6 grams cumulative exposure). Argyria has never been reported from dental SDF use.

Local adverse effects are generally mild and self-limiting. Accidental contact with the gingiva produces a temporary white or grayish discoloration that resolves within 24-48 hours through normal epithelial turnover. Contact with skin causes a brownish stain that fades over several days. Mucosal ulceration has been reported in isolated cases but heals without complication. Proper isolation and careful application technique minimize these risks.

Pulpal safety has been evaluated in histological studies. SDF application to deep carious lesions does not appear to cause pulp inflammation or necrosis when the pulp is healthy prior to treatment. However, SDF should not be applied when there is clinical or radiographic evidence of pulpal involvement, as silver penetration into the pulp chamber could theoretically exacerbate inflammation.

Integration into Caries Management Protocols

SDF occupies a unique position in the modern caries management armamentarium, functioning as a bridge between preventive measures and conventional restorative treatment. Its integration into clinical practice requires a shift from the traditional surgical paradigm to a medical model of caries management that emphasizes disease control over lesion excision.

The ADA's caries management pathways, developed in 2015 and updated subsequently, position SDF as a first-line option for non-cavitated and cavitated lesions in primary and permanent teeth where the lesion is accessible and there are no signs of pulpal involvement. For non-cavitated lesions, SDF complements fluoride varnish and sealants as part of a comprehensive preventive program. For cavitated lesions, SDF offers an alternative to traditional restoration, particularly when restorative treatment is not immediately feasible due to patient cooperation, access to care, or financial constraints.

In pediatric dentistry, SDF has become a cornerstone of caries management for very young children, those with special healthcare needs, and patients requiring interim stabilization before definitive treatment under general anesthesia. Clinical case series report successful use of SDF to manage early childhood caries in children as young as 12 months, with treatment performed in 2-3 minute appointments without the need for restraint or sedation.

Geriatric and special needs populations benefit substantially from SDF. Elderly patients with root caries, dementia, or physical limitations that complicate conventional treatment can receive SDF in nursing home settings, with minimal cooperation required. A 2022 systematic review by Hendre et al. reported that SDF arrested 70-80% of root caries lesions in community-dwelling and institutionalized elderly adults, with high patient and caregiver satisfaction.

Public health and school-based programs represent one of the most impactful applications of SDF. The atraumatic nature of SDF application allows it to be delivered by dental auxiliaries and trained non-dental personnel in community settings. The World Health Organization's inclusion of SDF in the Essential Medicines List reflects its importance as a public health intervention for caries control in underserved populations globally. In Brazil's national oral health program and Hong Kong's school dental care service, SDF-based caries management programs have reached tens of thousands of children annually, with documented reductions in untreated caries prevalence.

Future Directions and Research Priorities

The expanding clinical role of SDF is accompanied by active research addressing its limitations and exploring new applications. Key areas of ongoing investigation include the development of staining-reduced formulations, optimization of application frequency and concentration, combination therapies that synergize with SDF, and expansion of indications to include additional oral diseases.

Staining-reduced and staining-free silver fluoride formulations are a major research focus. The combination of SDF with glutathione, a tripeptide reducing agent, has been shown in vitro to reduce staining by controlling silver ion reduction while maintaining antimicrobial activity. Nano-silver fluoride preparations, where silver is pre-reduced to nanoparticle form, have demonstrated comparable caries-arresting efficacy with significantly reduced discoloration in laboratory studies. Multiple commercial entities are pursuing patent-protected SDF analogues that aim to eliminate the aesthetic barrier to anterior tooth treatment.

Optimal application protocols continue to be refined. While annual and biannual reapplication schedules are well-established, some evidence suggests that lesion-specific reapplication based on clinical monitoring of arrest status may be sufficient, reducing both cost and cumulative fluoride exposure. The minimum effective concentration of SDF also warrants further study; while 38% is the most commonly tested formulation, concentrations as low as 12% have shown clinically meaningful caries arrest rates in some populations.

Combination approaches that pair SDF with other minimally invasive treatments are gaining attention. The SMART technique, combining SDF with glass ionomer restorations, has been evaluated in several clinical trials with promising short-term results, showing improved restoration longevity compared to GIC alone. SDF combined with casein phosphopeptide-amorphous calcium phosphate (CPP-ACP) has demonstrated synergistic remineralization effects in vitro, with CPP-ACP providing bioavailable calcium and phosphate to complement the fluoride action of SDF.

Novel indications for SDF are being explored. Preliminary research suggests potential efficacy in managing dentinal hypersensitivity, arresting erosive tooth wear, disinfecting root canals as an intracanal medicament, and treating peri-implantitis. While these applications lack the mature evidence base supporting caries arrest, they illustrate the versatility of SDF's dual antimicrobial-remineralizing mechanism.

Health economic analyses consistently demonstrate the cost-effectiveness of SDF compared to conventional restorative treatment. A Markov model analysis by Hansen et al. (2020), published in the Journal of the American Dental Association, estimated that SDF treatment saved approximately $340 per child over a 3-year period compared to traditional restorative care, while achieving comparable or superior health outcomes. Cost-effectiveness is particularly pronounced in public health and school-based settings, where economies of scale further reduce per-child costs.

Conclusion

Silver diamine fluoride represents a paradigm shift in caries management, offering a minimally invasive, low-cost, and highly effective alternative to traditional restorative treatment. Its dual mechanism—combining the antimicrobial potency of silver with the remineralization capacity of fluoride—achieves caries arrest rates of approximately 80% with simple topical application. The straightforward clinical protocol, minimal infrastructure requirements, and excellent safety profile make SDF uniquely suited for diverse clinical settings, from private practices to remote community outreach programs.

The principal limitation—permanent black staining of arrested lesions—is a significant aesthetic concern that constrains its application in the anterior dentition. However, mitigation strategies including SMART restorations, potassium iodide application, and emerging staining-reduced formulations are progressively expanding the clinical scenarios in which SDF can be offered. The accumulating evidence base, international guideline endorsements, and WHO Essential Medicines List inclusion underscore SDF's established role in evidence-based dental practice.

As dentistry continues its evolution from a surgical model toward a medical model of caries management, SDF epitomizes the principles of minimally invasive dentistry: preserving tooth structure, prioritizing disease control, and improving access to care for underserved populations. Its continued integration into clinical practice guidelines, dental education curricula, and public health programs will undoubtedly accelerate the global effort to reduce the burden of untreated dental caries.